|
Effectiveness and Cost Impact of a Telecommunications System in COPD Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Effectiveness and Cost Impact of a Telecommunications System in COPD conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Effectiveness and Cost Impact of a Telecommunications System in COPD Clinical research trials and Effectiveness and Cost Impact of a Telecommunications System in COPD healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Effectiveness and Cost Impact of a Telecommunications System in COPD. Effectiveness and Cost Impact of a Telecommunications System in COPD Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Effectiveness and Cost Impact of a Telecommunications System in COPD clinical trial. Test subjects typically receive the most effective healthcare possible for their Effectiveness and Cost Impact of a Telecommunications System in COPD condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Effectiveness and Cost Impact of a Telecommunications System in COPD  Effectiveness and Cost Impact of a Telecommunications System in COPD
Effectiveness and Cost Impact of a Telecommunications System in COPD
For Condition: Lung Diseases, Obstructive
Status: Completed
Sponsor(s): Department of Veterans Affairs , Department of Veterans Affairs Health Services Research and Development Service
Synopsis: Chronic obstructive pulmonary disease (COPD) is one of the most common chronic illnesses in the adult population, and accounts for approximately 25,000 discharges from VA hospitals in a calendar year. Interventions that enhance symptom self-monitoring and increase understanding of COPD therapy may reduce the occurrence of COPD-related hospitalizations and other acute health care services. However, such interventions are labor-intensive and expensive, and typically require patients to go to a medical facility on a regular basis. A novel means of providing such interventions is the Telephone-Linked Computer (TLC) system, a computer-based telecommunications system that can monitor, educate, and counsel patients through regular automated conversations in patients? homes. In previous studies, we have demonstrated the applicability of TLC technology in the clinical monitoring of adults with chronic disease conditions such as hypertension and hypercholesterolemia. The overall goal of this project is to determine whether a TLC system for COPD care (TLC-COPD) leads to a reduction in emergency department (ED) visits and hospitalizations and to improved functional status and quality of life (QOL) in patients with COPD. The following specific objectives will be accomplished: (1) test the hypothesis that the addition of TLC-COPD to usual medical care reduces the use of acute health care services over a one-year follow-up period; (2) test the hypothesis that TLC-COPD use leads to improvements in functional status and QOL; (3) test the hypothesis that the reduction in the cost of care over the one-year follow-up period will exceed the cost of the TLC intervention; and (4) test the hypothesis that the TLC-COPD is cost effective compared with usual care in achieving improvements in functional status and QOL. Hypotheses will be tested by means of a randomized controlled trial involving subjects with COPD who receive care at two Boston-area VA hospitals. Subjects will be assigned to either TLC-COPD or a usual care control group.
Details:
Eligibility:
Study Type: Interventional, Educational/Counseling/Training, Randomized, Open Label, Active Control, Single Group Assignment
Minimum Age/Maximum Age: /
Genders: Male
Protocol Entry Criteria: COPD diagnosis; FEV, < _65% pred; FEV, /FVC<_85% pred
Total Enrollment: 300
Location and Contact Information:
VA Boston Health Care System
Boston, Massachusetts, 02130
United States
Additional Information:
Study ID Numbers: IIR 97-022;
Study Start Date: April 1998
Record last reviewed: October 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00012805
Other Lung Diseases, Obstructive Studies:
1. National Emphysema Treatment Trial (NETT)
2. Intervention for Resistant Pregnant Smokers
3. Clinical Trial of Acid Reflux Therapy in Asthma
4. Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)
5. Supplemental Selenium and Vitamin E and Pulmonary Function
Related Studies:
Other Lung Diseases, Obstructive Clinical Trials
Other Massachusetts Clinical Trials
Other Boston Clinical Trials
Effectiveness and Cost Impact of a Telecommunications System in COPD
|
|
|
|
|
|
|
|
